Comparative treatment planning on localized prostate carcinoma: Conformal photon-versus proton-based radiotherapy

Strahlentherapie und Onkologie

Volumn 181, Issue 7, 2005, Pages 448-455

  Mock, Ulrike ^a   Bogner, Joachim ^a   Georg, Dietmar ^a   Auberger, Thomas ^b   Pötter, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

IMRT; Prostate carcinoma; Proton therapy; Treatment planning

Indexed keywords

ARTICLE; BEAM THERAPY; BLADDER; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONFORMAL PHOTON THERAPY; CONTROLLED STUDY; FEMUR HEAD; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; PROSTATE; PROSTATE CARCINOMA; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTUM; RISK ASSESSMENT; SEMINAL VESICLE; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

FEMUR; HUMANS; MALE; NEOPLASM STAGING; PHOTONS; PROSTATIC NEOPLASMS; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; URINARY BLADDER;

EID: 21844435474     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-005-1317-7     Document Type: Article

References (39)

1. Adams E, Convery D, Cosgrove V, et al. Clinical implementation of dynamic and step- and shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiother Oncol 2004;70:1-10.
2. Aebersold D, Isaak B, Thalmann G, et al. Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer. Strahlenther Onkol 2004;180:351-7.
3. Amer A, Mott J, Mackay RI, et al. Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2003;56:199-207.
4. Armstrong J. Three-dimensional conformal radiation therapy: evidence-based treatment of prostate cancer. Radiother Oncol 2002;64:235-7.
5. Benk VA, Adams JA, Shipley WU, et al. Late rectal bleeding following combined x-ray and proton high dose irradiation for patients with stages T3-T4 prostate cancer. Int J Radiat Oncol Biol Phys 1993;26:551-7.
6. Boersma L, Van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;41:83-92.
7. Dearnaley D, Khoo V, Norman A, et al. Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet 1999;353:267-72.
8. De Meerleer G, Vakaet L, De Gersem W, et al. Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer. Strahlenther Onkol 2004;180:136-43.
9. De Meerleer G, Villeirs GM, Vakaet L, et al. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer. Strahlenther Onkol 2004;180:573-81.
10. Fiorino C, Cozzarini C, Vavassori V, et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 2002;64:1-12.
11. Georg D, Kroupa B. Pre-clinical evaluation of an inverse planning module for segmental MLC based IMRT delivery. Phys Med Biol 2002;47:N303-14.
12. Goldner G, Wachter-Gerstner N, Wachter S, et al. Akute Nebenwirkungen der Strahlentherapie bei 3-D-geplanter konformaler Bestrahlung des Prostatakarzinoms. Vergleich eines Patientenfragebogens und der Einschätzung durch den Arzt. Strahlenther Onkol 2003;179:320-7.
13. Greco C, Mazzetta C, Cattani F, et al. Finding dose-volume constrains to reduce late rectal toxicity following 3D conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 2003;69:215-22.
14. Hartford AC, Niemierko A, Adams JA, et al. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;36:721-30.
15. Hoinkis C, Hakenberg OW, Lehmann D, et al. Evaluation of dose-volume histograms after prostate seed implantation. 4-year experience. Strahlenther Onkol 2004;180:550-6.
16. Jackson A, Skwarchuk MW, Zelefsky MJ, et al. Later rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001;49:685-98.
17. Koper PC, Jansen P, Van Putten W, et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observation of a randomized trial. Radiother Oncol 2004;73:1-10.
18. Lennernäs B, Holmäng S, Hedelin H, HDR-Brachytherapie des Prostataadenokarzinoms in Kombination mit perkutaner Radiotherapie. Ein monoinstitutioneller Erfahrungsbericht der ersten 50 so behandelten Patienten. Strahlenther Onkol 2002;178:537-41.
19. Lomax AJ, Bortfeld T, Goitein G, et al. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol 1999;61:257-71.
20. Martinez A, Di Yan F, Lockman D, et al. Improvements in dose escalation using the process of adaptive radiotherapy combined with three dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001;50:1226-34.
21. Mayer R, Pummer K, Quehenberger F, et al. Analysis of competing risk parameters in irradiated prostate cancer patients Strahlenther Onkol 2003;179:452-6.
22. Neugut A, Ahsan H, Robinson E, et al. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 1997;79:1600-4.
23. Nguyen LN, Pollack A, Zagars GK, et al. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 1998;51:991-7.
24. Nutting CM, Convery DJ, Cosgrove VP, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:649-56.
25. Nuyttens JJ, Milito S, Rust PF, et al. Dose volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 2002;64:209-14.
26. Rancati T, Fiorino C, Gagliardi G, et al. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROSO101). Radiother Oncol 2004;73:21-32.
27. Rossi CJ, Slater JD, Reyes-Molyneux N, et al. Particle beam radiation therapy in prostate cancer: is there an advantage? Semin Radiat Oncol 1998;8:115-23.
28. Russel KJ, Caplan RJ, Laramore GE, et al. Photons versus fast neutrons external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized perspective trial. Int J Radiat Oncol Biol Phys 1993;28:47-54.
29. Schulte RW, Slater JD, Rossi CJ, et al. Value and perspectives of proton radiation therapy for limited stage prostate cancer. Radiother Oncol 2000;176:3-8.
30. Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I); multivariate analysis and dose response. Int J Radiat Oncol Biol Phys 2000;47:103-13.
31. Slater JD, Rossi CJ, Yonemoto LT, et al. Conformal proton therapy for early-stage prostate cancer. Urology 1999;53:978-84.
32. Slater JD, Rossi CJ, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004;59:348-52.
33. Storey MR, Pollack A, Zagars G, et al. Complications from radiotherapy dose escalation in prostate cancer; preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-42.
34. Tait DM, Nahum AE, Meyer LC, et al. Acute toxicity in pelvic radiotherapy: a randomized trial of conformal versus conventional treatment. Radiother Oncol 1997;42:121-36.
35. Vordermark D, Schwab M, Ness-Dourdoumas R, et al. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 2003;69:209-14.
36. Wachter S, Gerstner N, Goldner G, et al. Endoscopic scoring of late rectal mucosa damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol 2000;54:11-9.
37. Wachter-Gerstner N, Wachter S, Goldner G, et al. Biochemisches Ansprechen nach 3-D-konformaler Strahlentherapie des lokal begrenzten Prostatakarzinoms bei einer Dosis von 66 Gy: 4-Jahres-Ergebnisse. Strahlenther Onkol 2002;178:542-7.
38. Yonemoto L, Slater J, Rossi C, et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. Int J Radiat Oncol Biol Phys 1997;37:21-9.
39. Zelefsky MJ, Fuks Z, Leibel SA. Intensity modulated radiation therapy for prostate carcinoma. Semin Radiat Oncol 2002;12:229-37.